Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts (2020)

First Author: Shiu K
Attributed to:  MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2020.00079

Publication URI: http://dx.doi.org/10.3389/fimmu.2020.00079

Type: Journal Article/Review

Parent Publication: Frontiers in Immunology